TauRx Therapeutics / TauRx Pharmaceuticals Ltd, 2026-11-21: The manufacturer's own medical-professionals FAQ states that HMTM is an investigational medicine, not approved or licensed by any regulator, with efficacy and safety not established by any regulatory authority.
It is not approved or licensed by any medicines regulator and is not available to be prescribed.
TauRx Therapeutics / TauRx Pharmaceuticals Ltd, 2026-11-21: The manufacturer's own medical-professionals FAQ states that HMTM is an investigational medicine, not approved or licensed by any regulator, with efficacy and safety not established by any regulatory authority. Page undated: document_date is the access date 2026-11-21 (rules: access date, page undated). This is the single cleanest statement of regulatory status from the sponsor itself and is consistent with the MHRA correspondence in MTC-095. The same FAQ claims a 95% NfL reduction and a 35% reduction in brain shrinkage versus 'matched placebo controls' from a separate analysis (TRx-237-080) rather than the randomised arm. Study type: other.
